docetaxel anhydrous has been researched along with Menopause in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andre, F; Broglio, K; Hortobagyi, GN; Mackey, JR; Martin, M; Penault-Llorca, F; Pusztai, L; Roche, H | 1 |
| Groshen, S; Lee, AS; Lee, E; Nichols, P; Spicer, D | 1 |
| Antón, A; Cuevas, JM; Estévez, LG; Florián, J; Fortes, J; Herrero, A; Lobo, F; López-Vega, JM; Velasco, A | 1 |
| Fujiuchi, N; Okubo, K; Saeki, T; Takeuchi, H | 1 |
| Gnant, MF; Jakesz, R; Locker, GJ; Rudas, M; Schmidinger, M; Steger, GG; Taucher, S; Wenzel, C | 1 |
1 review(s) available for docetaxel anhydrous and Menopause
| Article | Year |
|---|---|
[Current status of adjuvant chemotherapy for breast cancer].
Topics: Anthracyclines; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Bridged-Ring Compounds; Chemotherapy, Adjuvant; Clinical Trials as Topic; Docetaxel; Dose-Response Relationship, Drug; Female; Humans; Menopause; Perioperative Care; Tamoxifen; Taxoids; Trastuzumab | 2006 |
2 trial(s) available for docetaxel anhydrous and Menopause
| Article | Year |
|---|---|
Weekly docetaxel as neoadjuvant chemotherapy for stage II and III breast cancer: efficacy and correlation with biological markers in a phase II, multicenter study.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Menopause; Middle Aged; Neoplasm Staging; Paclitaxel; Receptor, ErbB-2; Receptors, Estrogen; Spain; Taxoids; Treatment Outcome | 2003 |
Combined analysis of two phase II trials in patients with primary and advanced breast cancer with epidoxorubicin and docetaxel+granulocyte colony stimulating factor.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Docetaxel; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Menopause; Middle Aged; Neoadjuvant Therapy; Paclitaxel; Palliative Care; Prospective Studies; Survival Rate; Taxoids | 2002 |
2 other study(ies) available for docetaxel anhydrous and Menopause
| Article | Year |
|---|---|
Estrogen receptor expression and efficacy of docetaxel-containing adjuvant chemotherapy in patients with node-positive breast cancer: results from a pooled analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Docetaxel; Female; Follow-Up Studies; Humans; Menopause; Middle Aged; Neoplasm Recurrence, Local; Randomized Controlled Trials as Topic; Receptors, Estrogen; Taxoids | 2008 |
GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
Topics: Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Breast Neoplasms; Cyclophosphamide; Docetaxel; Doxorubicin; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Humans; Lymphatic Metastasis; Menopause; Middle Aged; Multivariate Analysis; Neoplasm Staging; Paclitaxel; Predictive Value of Tests; Taxoids; Treatment Outcome | 2011 |